Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zenlabs EthicaBOM:530697 +2.12%54 Days Payable is 200.69 as of Mar. 2026, which is 31% above its 10-year median of 153.16. GuruFocus rates BOM:530697 with a GF Score™ of 54/100 and a GF Value™ of ₹29.21 (Fairly Valued). The stock has 6 warning signs investors should review. Among 115 Medical Distribution companies, Zenlabs Ethica ranks better than 88.7% on this metric.
The historical rank and industry rank for Zenlabs Ethica's Days Payable or its related term are showing as below:
BOM:530697'
s Days Payable Range Over the Past 10 Years
Min: 129.18 Med: 153.16 Max: 167.43
Current: 166.38
During the past 13 years, Zenlabs Ethica's highest Days Payable was 167.43. The lowest was 129.18. And the median was 153.16.
BOM:530697's Days Payable is ranked better than 88.7% of 115
companies
in the Medical Distribution industry
Industry Median: 79.11
vs BOM:530697: 166.38
Zenlabs Ethica's Days Payable
increased
from Mar. 2025 (149.80) to Mar. 2026 (200.69).
It may suggest that Zenlabs Ethicadelayed paying its suppliers.
Zenlabs Ethica Days Payable Related Terms
Zenlabs Ethica Days Payable Historical Data
* Premium members only.
The historical data trend for Zenlabs Ethica's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:530697 vs MCK, CAH, COR: Days Payable Comparison
For the Medical Distribution subindustry, Zenlabs Ethica's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zenlabs Ethica Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Zenlabs Ethica's Days Payable distribution charts can be found below:
* The bar in red indicates where Zenlabs Ethica's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Zenlabs Ethica's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zenlabs Ethica (BOM:530697) has a Days Payable of 200.69 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zenlabs Ethica and its competitors. This is 31% above median its historical median of 153.16. Over the past decade, Zenlabs Ethica's Days Payable has ranged from 129.18 to 167.43. According to the industry distribution chart, Zenlabs Ethica ranks #13 out of 115 companies in the Medical Distribution industry, placing it in the top 11.3%.
Is Zenlabs Ethica's Days Payable too high?
Zenlabs Ethica's current Days Payable of 200.69 is 31% above median its 10-year median of 153.16. Over the past 10 years, this metric has ranged from a low of 129.18 to a high of 167.43. The Medical Distribution industry median Days Payable is 79.11. Zenlabs Ethica's value of 200.69 is 153.7% above this industry median. Based on the distribution chart, Zenlabs Ethica ranks #13 out of 115 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Zenlabs Ethica has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zenlabs Ethica's Days Payable compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Zenlabs Ethica ranks #13 out of 115 companies for Days Payable. This places Zenlabs Ethica in the top 11% of its industry — outperforming the majority of peers. The industry median Days Payable is 79.11. Zenlabs Ethica's value of 200.69 is 153.7% above this benchmark. Historically, Zenlabs Ethica's own Days Payable has ranged from 129.18 to 167.43 over the past decade. While the company's 10-year median is 153.16 vs. the industry median of 79.11, Zenlabs Ethica has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.11, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zenlabs Ethica's current Days Payable of 200.69 is 153.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zenlabs Ethica and its competitors. For the Medical Distribution industry, the median Days Payable is 79.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zenlabs Ethica's current Days Payable is 200.69, which is 31% above median its own 10-year median of 153.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenlabs Ethica stock overvalued right now?
Based on GuruFocus' analysis, Zenlabs Ethica (BOM:530697) is currently considered Fairly Valued. The stock's GF Value™ is ₹29.21, compared to a current price of ₹32.21 — trading 10.3% above its estimated fair value. The current Days Payable is 200.69, which is 31% above median its 10-year median of 153.16 and 153.7% above the Medical Distribution industry median of 79.11. Zenlabs Ethica's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Zenlabs Ethica (BOM:530697), the current Days Payable is 200.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zenlabs Ethica (BOM:530697) Overvalued in 2026?
Based on GuruFocus' analysis, Zenlabs Ethica stock appears to be overvalued.
The current stock price of ₹32.21 is trading 10.3% above its estimated GF Value™ of ₹29.21.
GuruFocus considers Zenlabs Ethica to be Fairly Valued.
Key valuation signals for BOM:530697:
Days Payable: 200.69 (31% above median its 10-year median of 153.16)
GF Value™: ₹29.21 vs. price of ₹32.21 (10.3% above fair value)
Industry Position: 153.7% above the Medical Distribution median (#13 of 115)
No single metric tells the full story. See the BOM:530697 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zenlabs Ethica Ltd is a pharmaceutical company engaged in the trading of pharmaceutical formulations. It manufactures and markets drugs which include Gastrointestinal disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps, and anti-Bacterial drugs, nutraceuticals, and others. In addition, The company offers more than 600 products across therapeutic segments.
54GF Score
Get the complete analysis for BOM:530697
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530697 has been successfully added to your 
